General situation of Hubei South Group Co., Ltd.

The total registered capital of the group company and each funded enterprise is 654.38+560 million yuan and the total assets are 434 million yuan. The main products of each funded enterprise of the group company are Mulan refined salt series, Lomefloxacin hydrochloride freeze-dried powder injection for Ogilvy, Yiaosu preparation, Zentinol nicotinate for Yimei injection, Fu Bao brand gas safety automatic alarm, etc., which enjoy high reputation in the domestic market.

In 2005, the investment enterprises of the Group Company realized an annual output value of 293,547,400 yuan in industry and construction, sales income of 26,065,438 yuan+262,000 yuan, total profits and taxes of 29,858,800 yuan and net profit of 1.02 1.36 million yuan. Calculated by comparable caliber, sales revenue, tax revenue, net profit, net assets and employee income have increased at an average annual rate of 13.86%, 9.3%, 18.9 1% and 7.3% respectively in recent five years. In the past five years, the capital invested by the group company and each invested enterprise has reached 6.54.38+0.7361.00 million yuan, and the average annual profitability has increased by more than 6.54.38+0.1.00 million yuan.